[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.158.79.216. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
August 9, 1941

SENSITIVITY OF PNEUMOCOCCI TO SULFAPYRIDINE: A RAPID QUALITATIVE TEST FOR RESISTANCE; CLINICAL EVALUATION OF THE PROBLEM

Author Affiliations

Los Angeles
From the Departments of Medicine and Bacteriology, University of Southern California School of Medicine, and the Los Angeles County Hospital.

JAMA. 1941;117(6):437-439. doi:10.1001/jama.1941.72820320002007a
Abstract

Differences in the sensitivity of pneumococci to sulfapyridine have been suggested since the earliest days of its use.1 MacLean, Rogers and Fleming2 observed decided differences both in vivo and in vitro, and developed, as did Macleod and Daddi,3 a strain resistant to sulfapyridine by passage of a sensitive strain through treated mice. These observations have been confirmed and extended4 and may be summarized as follows: Pneumococci differ profoundly in their sensitivity to the sulfonamides; resistant strains occur in nature; sensitive strains may become resistant when they are exposed to the drug in either the test tube, mouse or human being; resistant strains are probably permanently resistant.

The clinical implications of these results are most grave. The rational therapy of pneumococcic pneumonia demands knowledge of the sensitivity or resistance of the organism: chemotherapy in the absence of this knowledge is analogous to serotherapy in the absence of

First Page Preview View Large
First page PDF preview
First page PDF preview
×